Articles by Cynthia Challener, PhD - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Cynthia Challener, PhD

African Biopharma Market Presents Long-term Opportunities

Sep 1, 2014

Biopharma companies seeking to leverage opportunities in African market must adopt the right strategy to achieve success.

Need for Supply Chain Transparency is Acute

Biopharma manufacturers must reduce risk in their complex supply chains and establish effective monitoring and control systems.
Sep 1, 2014

Biopharma manufacturers must reduce risk in their complex supply chains and establish effective monitoring and control systems.

Supply Chain Security Tops Concerns for Biopharma Raw Materials

Sep 1, 2014

Biopharma are looking to reduce risk, increase performance, and optimize productivity in raw material development.

Exploring a New Approval Process for Continued Excipient Innovation

New excipients and improvements to existing excipients are needed to facilitate access to new drugs for patients.
Sep 1, 2014

New excipients and improvements to existing excipients are needed to facilitate access to new drugs for patients.

Acute Need for Supply Chain Transparency

Biopharma manufacturers must reduce the risk in their complex supply chains
Aug 4, 2014

Biopharma manufacturers must reduce the risk in their complex supply chains

Steady Progress Toward Continuous Flow API Synthesis

The pharma industry makes slow, but steady moves toward commercial-scale continuous processes for small-molecule API manufacturing.
Aug 4, 2014

The pharma industry makes slow, but steady moves toward commercial-scale continuous processes for small-molecule API manufacturing.

Pharma Investments Reflect Key Industry Trends

Shrinking facility size, growth of biologics, and emerging market demand influence pharma investments.
Aug 2, 2014

Shrinking facility size, growth of biologics, and emerging market demand influence pharma investments.

Risk Reduction Top Driver for Biopharmaceutical Raw Material Development

Customers are looking to reduce risk, increase performance, and optimize productivity.
Aug 2, 2014

Customers are looking to reduce risk, increase performance, and optimize productivity.

Automating Online Sampling of Bioprocesses

The Modular Automated Sampling Technology platform consists of a sterile sampling system, a sample scheduler and navigator for automated sampling and delivery of samples to analytical instruments, and a data-management system.
Jul 2, 2014

The Modular Automated Sampling Technology platform allows sampling of bioreactors.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
FindPharma Custom Search
Click here